SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiaks Phase 3 DAYBREAK trial met its primary endpoints for Zenkuda and tabirafusp-ted in wet AMD; Zenkudas six-month dosing durability and the planned BLA filing have fueled a sharp rally. Traders are celebrating the results and discussing a possible short squeeze, while others warn of profit-taking, dilution risk and the remaining path to approval.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

A persistent selloff is driving attention, with traders blaming elevated yields, dilution and insider selling, and weak buying demand; some also suspect shorting and options activity. Bulls counter that SoFis business is growing and point to its Mastercard stablecoin-settlement deal, viewing the decline as disconnected from the fundamentals, while bears expect further weakness.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDB shares are sharply lower after CEO CJ Desai stepped down to join Meta, less than a year into the role and just ahead of MongoDBs investor day; former CEO Dev Ittycheria was named interim CEO. Traders are split between concern over leadership uncertainty and the timing of the departure, and views that the selloff is an overreaction because the former CEO is back and the company reaffirmed its outlook.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is drawing attention for its persistent weakness alongside AI data-center peers, with traders citing macro and financing concerns despite optimism about the confirmed Brookwood/Delta Forge 2 project. The potential Meta connection remains unconfirmed, and the community is debating whether upcoming earnings and evidence of capacity coming online can ease concerns about execution and dilution.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Ampriuss federal defense grant to convert a domestic EV battery line for high-energy-density drone cells is driving attention, with bullish traders viewing it as validation and a path to scale. Others note the grant is not a purchase order or immediate revenue, and are frustrated that the initial enthusiasm faded amid weak price action.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Kodiak Sciences strong clinical readout is weighing on Ocular Therapeutix as traders reassess competition for wet AMD treatments and whether AXPAXLI can match or beat Kodiaks candidate. Some see the selloff as an overreaction given AXPAXLIs SOL-1 data and planned NDA path, while others view Kodiaks results as a threat to Oculars market position.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is under pressure as Treasury yields surge, with traders pointing to sticky inflation, hawkish rate expectations, and concerns about government borrowing and bond supply. The discussion is split between expectations of further bond losses and dip-buying bets that yields may eventually retreat.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Rising Treasury yields and surging oil prices tied to the Iran conflict are weighing on the broader market and driving concern about persistent inflation and tighter Fed policy. Traders are split between expecting further downside and viewing dips as buying opportunities, with some anticipating a rebound around Trump-related headlines.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is drawing attention after a sharp selloff to a seven-week low, as rising Treasury yields and expectations for another Fed rate hike weigh on non-yielding gold. Traders are split between buying the dip on longer-term debt and safe-haven concerns and expecting further downside while yields remain elevated.

The Charles Schwab Corp. is a savings and loan holding company, which engages in the provision of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. It operates through the Investor Services and Advisor Services segments. The Investor Services segment includes retail brokerage, investment advisory, and banking and trust services to individual investors, retirement plan and business services, as well as other corporate brokerage services, to businesses and employees. The Advisor Services segment provides custodial, trading, banking and trust, and support services to independent registered investment advisors, independent retirement advisors, and recordkeepers. The company was founded by Charles Robert Schwab in 1986 and is headquartered in Westlake, TX.

Charles Schwab Corp.

Schwab and thinkorswim platform disruptions, including login and order-entry problems and reports of inaccurate quotes, are driving the discussion. Traders are expressing frustration over missed or disrupted trades, with some calling for compensation or legal action and considering switching brokers; no article directly verifies the catalyst.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PGNY vs. CRL: Which Stock Is the Better Value Option?

Concentra Group Holdings Parent, Inc. (CON) Hits Fresh High: Is There Still Room to Run?

Concentra (CON) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Wall Street Analysts Predict a 25.23% Upside in Progyny (PGNY): Here's  What You Should Know

The mean of analysts' price targets for Progyny (PGNY) points to a 25.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Bet on These 4 Top-Performing Liquid Stocks to Maximize Returns

MNDY, MTCH, PGNY and WK make the cut as the top liquid stocks, each boasting strong liquidity, growth attributes and operational efficiency.

Progyny (PGNY) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Boost Your Portfolio Returns With These 4 Top-Ranked Liquid Stocks

 IVZ, HUBS, HNGE and PGNY make the cut as the top liquid stocks, each boasting strong liquidity, growth attributes and operational efficiency.

Why Progyny Stock Plunged, Then Gradually Recovered Today

Key PointsProgyny's sales and adjusted earnings per share grew by 5% and 15% in the second quarter...

Progyny (PGNY) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Progyny (PGNY) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Progyny (PGNY) Q2 Earnings and Revenues Beat Estimates

Progyny (PGNY) delivered earnings and revenue surprises of +7.84% and +0.38%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

MTD Second Quarter Earnings Beat Estimates on China-Led Sales Growth

MTD beats Q2 earnings estimates as strong China and emerging-market sales fuel growth, while the company raises its 2026 sales and earnings outlook.

Progyny, Inc. is a fertility benefits management company. It provides fertility solutions to employers, managing IUI, in vitro fertilization (IVF), egg freezing, and other fertility treatments. It operates through one segment: fertility and pharmacy benefits solutions. It also delivers treatment services and access to the firm’s network of fertility specialist. The company was founded on April 3, 2008 and is headquartered in New York, NY.

Progyny Inc

Progyny Stock Logs Best Day In 2 Months As BofA Calls Trump IVF Policy ‘Incremental Positive’ — Traders Eye More Upside

Equity

Neutral Sentiment

Iran/Middle East

Tariffs/trade policy

Economy/the $5K dividend

Something else entirely

President Trump is set to make an announcement from the Oval Office at 2pm EST today, with the White House keeping the topic under wraps. What do you think it&#39;s about? Drop a comment with your prediction.

Stocktwits

President Trump is set to make an announcement from the Oval Office at 2pm EST today, with the White House keeping the topic under wraps. What do you think it's about? Drop a comment with your prediction.

Current Price	$25.67
Prev Close	$25.44
Open	$25.41
Dividend Yield	0.00%
50-Day Moving Average	$27.88
Beta	0.49
Avg. Volume	1.17M
PE Ratio	27.63

52-Week High	$33.07
52-Week Low	$16.10
Market Capitalization	$1.95B
EPS (Annual)	$0.6512
Price to Book	4.34
Revenue Per Employee	$1.51M

Feed

News

Sentiment

Earnings

Fundamentals

Info

PGNY Fundamentals